Leucine-rich repeat containing 4 act as an autophagy inhibitor that restores sensitivity of glioblastoma to temozolomide
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Leucine-rich repeat containing 4 act as an autophagy inhibitor that restores sensitivity of glioblastoma to temozolomide
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-05
DOI
10.1038/s41388-020-1312-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Delivery of MGMT mRNA to glioma cells by reactive astrocyte-derived exosomes confers a temozolomide resistance phenotype
- (2018) Tianfu Yu et al. CANCER LETTERS
- Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response
- (2018) Sabine Hombach-Klonisch et al. PHARMACOLOGY & THERAPEUTICS
- NGL-2 Deletion Leads to Autistic-like Behaviors Responsive to NMDAR Modulation
- (2018) Seung Min Um et al. Cell Reports
- Synapse maintenance and restoration in the retina by NGL2
- (2018) Florentina Soto et al. eLife
- Deptor: not only a mTOR inhibitor
- (2017) Valeria Catena et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities
- (2017) Fiona M. Menzies et al. NEURON
- Hypoxia ameliorates intestinal inflammation through NLRP3/mTOR downregulation and autophagy activation
- (2017) Jesus Cosin-Roger et al. Nature Communications
- Novel Therapy for Glioblastoma Multiforme by Restoring LRRC4 in Tumor Cells: LRRC4 Inhibits Tumor-Infitrating Regulatory T Cells by Cytokine and Programmed Cell Death 1-Containing Exosomes
- (2017) Peiyao Li et al. Frontiers in Immunology
- Targeting autophagy to sensitive glioma to temozolomide treatment
- (2016) Yuanliang Yan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The D Domain of LRRC4 anchors ERK1/2 in the cytoplasm and competitively inhibits MEK/ERK activation in glioma cells
- (2016) Zeyou Wang et al. Journal of Hematology & Oncology
- Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas
- (2015) Alfeu Zanotto-Filho et al. CANCER LETTERS
- NGL-2 Is a New Partner of PAR Complex in Axon Differentiation
- (2015) G. Xu et al. JOURNAL OF NEUROSCIENCE
- Function and mechanism of tumor suppressor gene LRRC4/NGL-2
- (2015) Peiyao Li et al. Molecular Cancer
- An Evolving Role for DEPTOR in Tumor Development and Progression
- (2015) Zhiwei Wang et al. NEOPLASIA
- Chloroquine potentiates temozolomide cytotoxicity by inhibiting mitochondrial autophagy in glioma cells
- (2014) Yusuke S. Hori et al. JOURNAL OF NEURO-ONCOLOGY
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- Current evidence of temozolomide and bevacizumab in treatment of gliomas
- (2014) Danop Nanegrungsunk et al. NEUROLOGICAL RESEARCH
- mTOR and autophagy: A dynamic relationship governed by nutrients and energy
- (2014) E.A. Dunlop et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Understanding and Targeting Alkylator Resistance in Glioblastoma
- (2014) W. Wick et al. Cancer Discovery
- Autophagy
- (2013) Amber N. Hale et al. Autophagy
- Autophagy-Mediated Tumor Promotion
- (2013) Jessie Yanxiang Guo et al. CELL
- Autophagy and human diseases
- (2013) Peidu Jiang et al. CELL RESEARCH
- The role of autophagy in neurodegenerative disease
- (2013) Ralph A Nixon NATURE MEDICINE
- Autophagy and apoptosis dysfunction in neurodegenerative disorders
- (2013) Saeid Ghavami et al. PROGRESS IN NEUROBIOLOGY
- Emerging insights into the molecular and cellular basis of glioblastoma
- (2012) G. P. Dunn et al. GENES & DEVELOPMENT
- Selective autophagy mediated by autophagic adapter proteins
- (2011) Terje Johansen et al. Autophagy
- Autophagy modulation for cancer therapy
- (2011) Zhineng J. Yang et al. CANCER BIOLOGY & THERAPY
- DEPTOR, an mTOR Inhibitor, Is a Physiological Substrate of SCFβTrCP E3 Ubiquitin Ligase and Regulates Survival and Autophagy
- (2011) Yongchao Zhao et al. MOLECULAR CELL
- mTOR Generates an Auto-Amplification Loop by Triggering the βTrCP- and CK1α-Dependent Degradation of DEPTOR
- (2011) Shanshan Duan et al. MOLECULAR CELL
- Autophagy Signaling Through Reactive Oxygen Species
- (2010) Ju Huang et al. ANTIOXIDANTS & REDOX SIGNALING
- DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival
- (2009) Timothy R. Peterson et al. CELL
- mTOR and cancer: many loops in one pathway
- (2009) Alejo Efeyan et al. CURRENT OPINION IN CELL BIOLOGY
- Trans-synaptic adhesion between NGL-3 and LAR regulates the formation of excitatory synapses
- (2009) Jooyeon Woo et al. NATURE NEUROSCIENCE
- Stem Cell–Related “Self-Renewal” Signature and High Epidermal Growth Factor Receptor Expression Associated With Resistance to Concomitant Chemoradiotherapy in Glioblastoma
- (2008) Anastasia Murat et al. JOURNAL OF CLINICAL ONCOLOGY
- Netrin-G2 and netrin-G2 ligand are both required for normal auditory responsiveness
- (2007) W. Zhang et al. GENES BRAIN AND BEHAVIOR
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started